Minerva Neurosciences (NERV)
(Delayed Data from NSDQ)
$3.11 USD
+0.05 (1.63%)
Updated Jul 29, 2024 03:59 PM ET
After-Market: $3.11 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth B Momentum C VGM
Brokerage Reports
0 items in cart
Minerva Neurosciences, Inc [NERV]
Reports for Purchase
Showing records 41 - 43 ( 43 total )
Company: Minerva Neurosciences, Inc
Industry: Medical - Drugs
Another Win for MIN-202 Differentiates Profile Further
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Minerva Neurosciences, Inc
Industry: Medical - Drugs
Initiating Coverage on Alkermes, Minerva; Assuming Coverage of Trevena
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Minerva Neurosciences, Inc
Industry: Medical - Drugs
A Name for Unmet Needs in Psychiatry; Initiate at Buy With $22 Price Target
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D